A potent, cell-permeable, irreversible, ATP-competitive and selective inhibitor of EGF receptor (EGFR) tyrosine kinase activity (IC50 = 700 pM). Does not inhibit other protein kinases. Acts by binding to the catalytic domain of the EGFR with a 1:1 stoichiometry and alkylating Cys773. Excellent antitumor agent in vivo.
|
Product information
|
|
Form
|
Orange-yellow solid
|
|
Primary Target
|
EGFR
|
|
Primary Target IC50
|
900 pM
|
|
Molar mass
|
369.2
|
|
Protect from Light
|
Yes
|
|
Packaged under inert gas
|
Yes
|
|
Cell permeable
|
Yes
|
|
Purity
|
≥95% by HPLC
|
|
Solubility
|
DMSO
|
|
Chemical formula
|
C17H13BrN4O
|
|
Store and ship information
|
|
|
|
Storage
|
-20°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|